Skip to main content

Articles

Page 60 of 70

  1. This study examined the population-based use and outcomes of brain radiotherapy (BRT) for brain metastases (BM) from breast cancer with a focus on repeat BRT in the trastuzumab era.

    Authors: Irene Karam, Alan Nichol, Ryan Woods and Scott Tyldesley
    Citation: Radiation Oncology 2011 6:181
  2. This study seeks to increase clinical operational efficiency and accelerator beam consistency by retrospectively investigating the application of statistical process control (SPC) to linear accelerator beam st...

    Authors: Charles M Able, Carnell J Hampton, Alan H Baydush and Michael T Munley
    Citation: Radiation Oncology 2011 6:180
  3. To define the dosimetric coverage of level I/II axillary volumes and the lung volume irradiated in postmastectomy radiotherapy (PMRT) following tissue expander placement.

    Authors: James K Russo, Kent E Armeson, Ryan Rhome, Michele Spanos and Jennifer L Harper
    Citation: Radiation Oncology 2011 6:179
  4. To investigate combining unmodulated electron beams with intensity-modulated radiation therapy to improve dose distributions for superficial head and neck cancers, and to compare mixed beam plans with helical tom...

    Authors: Olivier Blasi, Jonas D Fontenot, Robert S Fields, John P Gibbons and Kenneth R Hogstrom
    Citation: Radiation Oncology 2011 6:178
  5. Targeted drugs have augmented the cancer treatment armamentarium. Based on the molecular specificity, it was initially believed that these drugs had significantly less side effects. However, currently it is ac...

    Authors: Maximilian Niyazi, Cornelius Maihoefer, Mechthild Krause, Claus Rödel, Wilfried Budach and Claus Belka
    Citation: Radiation Oncology 2011 6:177
  6. To explore the risk factors of distant brain failure (DBF) for patients with brain metastasis (BM) who were treated with stereotactic radiotherapy alone and to group the patients on the basis of their risk lev...

    Authors: Xiu-jun Chen, Jian-ping Xiao, Xiang-pan Li, Xue-song Jiang, Ye Zhang, Ying-jie Xu, Jian-rong Dai and Ye-xiong Li
    Citation: Radiation Oncology 2011 6:175
  7. Radiation induced secondary cancers are a rare but severe late effect after breast conserving therapy. Intraoperative radiotherapy (IORT) is increasingly used during breast conserving surgery. The purpose of t...

    Authors: Muhammad Hammad Aziz, Frank Schneider, Sven Clausen, Elena Blank, Carsten Herskind, Muhammad Afzal and Frederik Wenz
    Citation: Radiation Oncology 2011 6:174
  8. Conventional external beam radiotherapy is a standard procedure for treatment of spinal metastases. In case of progression spinal cord tolerance limits further radiotherapy in pre-irradiated areas. Spinal ster...

    Authors: Katharina Nikolajek, Markus Kufeld, Alexander Muacevic, Berndt Wowra, Maximilian Niyazi and Ute Ganswindt
    Citation: Radiation Oncology 2011 6:173
  9. Spinal radiosurgery is a quickly evolving technique in the radiotherapy and neurosurgical communities. However, the methods of spine radiosurgery have not been standardized. This article describes the results ...

    Authors: Matthias Guckenberger, Reinhart A Sweeney, John C Flickinger, Peter C Gerszten, Ronald Kersh, Jason Sheehan and Arjun Sahgal
    Citation: Radiation Oncology 2011 6:172
  10. It has been postulated that ionizing radiation induces breast cancers among atomic bomb (A-bomb) survivors. We have reported a higher incidence of HER2 and C-MYC oncogene amplification in breast cancers from A-bo...

    Authors: Masahiro Oikawa, Koh-ichiro Yoshiura, Hisayoshi Kondo, Shiro Miura, Takeshi Nagayasu and Masahiro Nakashima
    Citation: Radiation Oncology 2011 6:168
  11. Radiotherapy (RT) remains an effective treatment in patients with acromegaly refractory to medical and/or surgical interventions, with durable tumor control and biochemical remission; however, there are still ...

    Authors: Giuseppe Minniti, Claudia Scaringi and Riccardo Maurizi Enrici
    Citation: Radiation Oncology 2011 6:167
  12. Brain metastases occur in 30-50% of Non-small cell lung cancer (NSCLC) patients and confer a worse prognosis and quality of life. These patients are usually treated with Whole-brain radiotherapy (WBRT) followe...

    Authors: Oscar Arrieta, Cynthia Villarreal-Garza, Jesús Zamora, Mónika Blake-Cerda, María D de la Mata, Diego G Zavala, Saé Muñiz-Hernández and Jaime de la Garza
    Citation: Radiation Oncology 2011 6:166
  13. [18F]FAZA is a PET biomarker with great potential for imaging tumor hypoxia. Aim of our study was to compare [18F]FAZA uptake in mice with subcutaneous exogenous CT26 colon carcinomas and endogenous polyoma middl...

    Authors: Florian C Maier, Manfred Kneilling, Gerald Reischl, Funda Cay, Daniel Bukala, Andreas Schmid, Martin S Judenhofer, Martin Röcken, Hans-Jürgen Machulla and Bernd J Pichler
    Citation: Radiation Oncology 2011 6:165
  14. The Monte Carlo code GEANT4 was used to implement first steps towards a treatment planning program for fast-neutron therapy at the FRM II research reactor in Garching, Germany. Depth dose curves were calculate...

    Authors: Sylvia Garny, Werner Rühm, Maria Zankl, Franz M Wagner and Herwig G Paretzke
    Citation: Radiation Oncology 2011 6:163
  15. to evaluate activity and toxicity of a sequential treatment in advanced, non metastatic, mostly unresectable, head and neck squamous cell carcinoma.

    Authors: Stefano Pergolizzi, Anna Santacaterina, Barbara Adamo, Tindara Franchina, Nerina Denaro, Pina Ferraro, Giusy RR Ricciardi, Nicola Settineri and Vincenzo Adamo
    Citation: Radiation Oncology 2011 6:162
  16. Neoadjuvant chemoradiotherapy is the treatment of choice in advanced rectal cancer, even though there are many patients who will not benefit from it. There are still no effective methods for predicting which p...

    Authors: Chiara Molinari, Michela Ballardini, Nazario Teodorani, Massimo Giannini, Wainer Zoli, Ermanno Emiliani, Enrico Lucci, Alessandro Passardi, Paola Rosetti, Luca Saragoni, Massimo Guidoboni, Dino Amadori and Daniele Calistri
    Citation: Radiation Oncology 2011 6:161
  17. Brain metastases afflict approximately half of patients with metastatic melanoma (MM) and small cell lung cancer (SCLC) and represent the direct cause of death in 60 to 70% of those affected. Standard of care ...

    Authors: Kirtesh Patel, Nicole A Doudican, Peter B Schiff and Seth J Orlow
    Citation: Radiation Oncology 2011 6:160
  18. The quality of the interdisciplinary interface in oncological treatment between surgery, pathology and radiotherapy is mainly dependent on reliable anatomical three-dimensional (3D) allocation of specimen and ...

    Authors: Harald Essig, Majeed Rana, Andreas Meyer, André M Eckardt, Horst Kokemueller, Constantin von See, Daniel Lindhorst, Frank Tavassol, Martin Ruecker and Nils-Claudius Gellrich
    Citation: Radiation Oncology 2011 6:159
  19. To assess the accuracy of patient repositioning and clinical outcomes of frameless stereotactic radiosurgery (SRS) for brain metastases using a stereotactic mask fixation system.

    Authors: Giuseppe Minniti, Claudia Scaringi, Enrico Clarke, Maurizio Valeriani, Mattia Osti and Riccardo Maurizi Enrici
    Citation: Radiation Oncology 2011 6:158
  20. Stereotactic radiosurgery/radiotherapy procedures are known to deliver a very high dose per fraction, and thus, the corresponding peripheral dose could be a limiting factor for the long term surviving patients...

    Authors: Vassiliki Vlachopoulou, Christos Antypas, Harry Delis, Argyrios Tzouras, Nikolaos Salvaras, Dimitrios Kardamakis and George Panayiotakis
    Citation: Radiation Oncology 2011 6:157
  21. Radiation therapy is routinely prescribed for high-grade malignant gliomas. However, the efficacy of this therapeutic modality is often limited by the occurrence of radioresistance, reflected as a diminished s...

    Authors: Carlos A Fedrigo, Ivana Grivicich, Daniel P Schunemann, Ivan M Chemale, Daiane dos Santos, Thais Jacovas, Patryck S Boschetti, Geraldo P Jotz, Aroldo Braga Filho and Adriana B da Rocha
    Citation: Radiation Oncology 2011 6:156
  22. To report the clinical outcome after a Single Shot 3D-CRT PBI (SSPBI) in breast cancer patients after conservative surgery (ClinicalTrials.gov Identifier: NCT01316328).

    Authors: Paola Pinnarò, Stefano Arcangeli, Carolina Giordano, Giorgio Arcangeli, Fabrizio Ambesi Impiombato, Valentina Pinzi, Giuseppe Iaccarino, Antonella Soriani, Valeria Landoni and Lidia Strigari
    Citation: Radiation Oncology 2011 6:155
  23. Although 3D-conformal accelerated partial breast irradiation (APBI) is widely used, several questions still remain such as what are the optimal treatment planning modalities. Indeed, some patients may have an ...

    Authors: Mohamed El Nemr, Steve Heymann, Rodolfe Verstraet, Bruno Biron, Fares Azoury, Hugo Marsiglia and Céline Bourgier
    Citation: Radiation Oncology 2011 6:154
  24. In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen (> 1000 miRNAs) from paraffin tissues followed by a bio-mathematical analysis was performed.

    Authors: Maximilian Niyazi, Franz Zehentmayr, Olivier M Niemöller, Sabina Eigenbrod, Hans Kretzschmar, Klaus Schulze-Osthoff, Jörg-Christian Tonn, Mike Atkinson, Simone Mörtl and Claus Belka
    Citation: Radiation Oncology 2011 6:153
  25. Frequently, three-dimensional (3D) conformal beams are used in lung cancer stereotactic body radiotherapy (SBRT). Recently, volumetric modulated arc therapy (VMAT) was introduced as a new treatment modality. V...

    Authors: Geoffrey G Zhang, Lichung Ku, Thomas J Dilling, Craig W Stevens, Ray R Zhang, Weiqi Li and Vladimir Feygelman
    Citation: Radiation Oncology 2011 6:152
  26. To evaluate the cardiac toxicity of radiotherapy (RT) in breast cancer (BC) patients employing myocardial perfusion imaging (MPI) with Tc-99 m Tetrofosmin - single photon emission computer tomography (T-SPECT).

    Authors: Chrissa Sioka, Thomas Exarchopoulos, Ifigenia Tasiou, Eftychia Tzima, Nikolaos Fotou, Antonio Capizzello, Vasilios Ragos, Periklis Tsekeris and Andreas Fotopoulos
    Citation: Radiation Oncology 2011 6:151
  27. To evaluate prognostic factors in salvage radiotherapy (RT) for patients with pre-RT prostate-specific antigen (PSA) < 1.0 ng/ml.

    Authors: Rei Umezawa, Hisanori Ariga, Yoshihiro Ogawa, Keiichi Jingu, Haruo Matsushita, Ken Takeda, Keisuke Fujimoto, Toru Sakayauchi, Toshiyuki Sugawara, Masaki Kubozono, Kakutaro Narazaki, Eiji Shimizu, Yoshihiro Takai and Shogo Yamada
    Citation: Radiation Oncology 2011 6:150
  28. To investigate toxicity and efficacy in high-risk malignant salivary gland tumors (MSGT) of the head and neck. Local control in R2-resected adenoid cystic carcinoma was already improved with a combination of I...

    Authors: Alexandra D Jensen, Anna V Nikoghosyan, Swantje Ecker, Malte Ellerbrock, Jürgen Debus, Klaus K Herfarth and Marc W Münter
    Citation: Radiation Oncology 2011 6:149
  29. Vaults are evolutionary highly conserved ribonucleoproteins particles with a hollow barrel-like structure. The main component of vaults represents the 110 kDa major vault protein (MVP), whereas two minor vault...

    Authors: Pedro C Lara, Martin Pruschy, Martina Zimmermann and Luis Alberto Henríquez-Hernández
    Citation: Radiation Oncology 2011 6:148
  30. To compare volumetric-modulated arc therapy plans with conventional radiation therapy (3D-CRT) plans in pancreatic and bile duct cancers, especially for bilateral kidney preservation.

    Authors: Sabine Vieillot, David Azria, Olivier Riou, Carmen Llacer Moscardo, Jean-Bernard Dubois, Norbert Aillères and Pascal Fenoglietto
    Citation: Radiation Oncology 2011 6:147
  31. The retroperitoneal margin is a common site of positive surgical margins in patients with resectable pancreatic cancer. Preoperative margin-intensive therapy (MIT) involves delivery of a single high dose of ab...

    Authors: John H Heinzerling, Ross Bland, John C Mansour, Roderich E Schwarz, Ezequiel Ramirez, Chuxiong Ding, Ramzi Abdulrahman, Thomas P Boike, Timothy Solberg, Robert D Timmerman and Jeffrey J Meyer
    Citation: Radiation Oncology 2011 6:146
  32. Image-guided radiotherapy (IGRT) increases the accuracy of treatment delivery through daily target localisation. We report on toxicity symptoms experienced during radiotherapy treatment, with and without IGRT ...

    Authors: Suki Gill, Jessica Thomas, Chris Fox, Tomas Kron, Aldo Rolfo, Mary Leahy, Sarat Chander, Scott Williams, Keen Hun Tai, Gillian M Duchesne and Farshad Foroudi
    Citation: Radiation Oncology 2011 6:145
  33. Prostate cancer (PrCa) displays resistance to radiotherapy (RT) and requires radiotherapy dose escalation which is associated with greater toxicity. This highlights a need to develop radiation sensitizers to i...

    Authors: Ayesha Rashid, Caiqiong Liu, Toran Sanli, Evangelia Tsiani, Gurmit Singh, Robert G Bristow, Ian Dayes, Himu Lukka, James Wright and Theodoros Tsakiridis
    Citation: Radiation Oncology 2011 6:144
  34. Spinal cord stimulators (SCS) are a well-recognised treatment modality in the management of a number of chronic neuropathic pain conditions, particularly failed back syndrome and radiculopathies. The implantab...

    Authors: Lorraine Walsh, Daipayan Guha, Thomas G Purdie, Philippe Bedard, Alexandra Easson, Fei-Fei Liu and Mojgan Hodaie
    Citation: Radiation Oncology 2011 6:143
  35. To evaluate the daily total error shift patterns on post-prostatectomy patients undergoing image guided radiotherapy (IGRT) with a diagnostic quality computer tomography (CT) on rails system.

    Authors: Ronaldo Cavalieri, Hiram A Gay, Jingxia Liu, Maria C Ferreira, Helvecio C Mota, Claudio H Sibata and Ron R Allison
    Citation: Radiation Oncology 2011 6:142
  36. To analyze the differences between the intensity-modulated radiotherapy (IMRT), single/partial-arc volumetric modulated arc therapy (SA/PA-VMAT) techniques in treatment planning for locally advanced lung cancer.

    Authors: Xiaoqin Jiang, Tao Li, Yongmei Liu, Lin Zhou, Yong Xu, Xiaojuan Zhou and Youling Gong
    Citation: Radiation Oncology 2011 6:140
  37. Laser acceleration of protons and heavy ions may in the future be used in radiation therapy. Laser-driven particle beams are pulsed and ultra high dose rates of >109 Gy s-1may be achieved. Here we compare the rad...

    Authors: Susanne Auer, Volker Hable, Christoph Greubel, Guido A Drexler, Thomas E Schmid, Claus Belka, Günther Dollinger and Anna A Friedl
    Citation: Radiation Oncology 2011 6:139
  38. Chest wall injury after stereotactic radiotherapy (SRT) for primary lung cancer has recently been reported. However, its detailed imaging findings are not clarified. So this study aimed to fully characterize t...

    Authors: Atsushi Nambu, Hiroshi Onishi, Shinichi Aoki, Tsuyota Koshiishi, Kengo Kuriyama, Takafumi Komiyama, Kan Marino, Masayuki Araya, Ryo Saito, Lichto Tominaga, Yoshiyasu Maehata, Eiichi Sawada and Tsutomu Araki
    Citation: Radiation Oncology 2011 6:137
  39. Oral cavity cancers (ORC) are the most common cancers, and standard treatment is radical surgery with postoperative radiotherapy. However, locoregional failure remains a major problem, indicating radioresistan...

    Authors: Chien-Yu Lin, Ting-Yang Lin, Hung-Ming Wang, Shiang-Fu Huang, Kang-Hsing Fan, Chun-Ta Liao, I-How Chen, Li-Yu Lee, Yen-Liang Li, Yin-Ju Chen, Ann-Joy Cheng and Joseph T Chang
    Citation: Radiation Oncology 2011 6:136
  40. We aimed to assess outcomes of patients with anal cancer who underwent intensity-modulated radiotherapy (IMRT) and received less than 1.80 Gy/day.

    Authors: Jason A Call, Michael G Haddock, J Fernando Quevedo, David W Larson and Robert C Miller
    Citation: Radiation Oncology 2011 6:134
  41. Sublethal photon irradiation was recently suspected to increase tumor cell motility and promote locoregional recurrence of disease. This study was set up to describe mechanisms underlying increased glioma cell...

    Authors: Stefan Rieken, Daniel Habermehl, Angela Mohr, Lena Wuerth, Katja Lindel, Klaus Weber, Jürgen Debus and Stephanie E Combs
    Citation: Radiation Oncology 2011 6:132
  42. Although the nodal ratio (NR) has been recognized as a prognostic factor in breast cancer, its clinical implication in patients with 1-3 positive nodes (N1) remains unclear. Here, we evaluated the prognostic v...

    Authors: Tae Jin Han, Eun Young Kang, Wan Jeon, Sung-Won Kim, Jee Hyun Kim, Yu Jung Kim, So Yeon Park, Jae Sung Kim and In Ah Kim
    Citation: Radiation Oncology 2011 6:131

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions